These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30905706)

  • 1. Predicting Drug Binding to Human Serum Albumin and Alpha One Acid Glycoprotein in Diseased and Age Patient Populations.
    McNamara PJ; Meiman D
    J Pharm Sci; 2019 Aug; 108(8):2737-2747. PubMed ID: 30905706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
    Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
    J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on binding of drug to serum protein].
    Otagiri M
    Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Plasma Protein Binding on the Pharmacokinetics of Erdafitinib: Results of an Integrated Cross-Study Analysis.
    Li LY; Guo Y; Gonzalez M; Ouellet D
    J Clin Pharmacol; 2020 Mar; 60(3):391-399. PubMed ID: 31602692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Plasticizer DEHP in Blood Collection Bags on Human Plasma Fraction Unbound Determination for Alpha-1-Acid Glycoprotein (AAG) Binding Drugs.
    Ingram N; Dishinger C; Wood J; Hutzler JM; Smith S; Huskin M
    AAPS J; 2018 Nov; 21(1):5. PubMed ID: 30446887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha-1-glycoprotein and its interactions with drugs.
    Israili ZH; Dayton PG
    Drug Metab Rev; 2001 May; 33(2):161-235. PubMed ID: 11495502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
    Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
    Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
    Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
    Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
    Wanwimolruk S; Denton JR
    J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.
    Urien S; Morin D; Renouard A; Rocher I; Tillement JP
    Eur J Clin Pharmacol; 1988; 34(4):381-5. PubMed ID: 2900145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.